ArticleGynecologic oncology reports2026
Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancer.
Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The impact of pre-operative frailty on outcomes in patients with endometrial cancer is not well studied. The primary aim of this study was to assess the association between preoperative frailty scores and postoperative complications in patients with advanced-stage endometrial cancer. Methods: This is a retrospective cohort study of patients who underwent hysterectomy for advanced-stage endometrial cancer at a single institution. Frailty was defined using the modified frailty index (mFI ≥ 2). Complications were measured with the Comprehensive Complication Index (CCI). Results: A total of 62 were included; 17 met criteria for frail (F) based on mFI. In the non-frail (NF) cohort, 11 patients underwent open surgery vs. 4 in F. There were 34 NF patients in the MIS group, and 13 in F. Complications occurred in 29.4% F vs. 28.9% NF patients, p = 1.00), in the open surgery subgroup (50.0% F vs. 45.5% NF, p = 1.00) and in the minimally invasive surgery subgroup (23.1% F vs. 23.5% NF, p = 1.00). Those with complications had similar median CCI scores (22.6F vs. 24.2 NF, p = 0.84). Median days to adjuvant therapy were similar (39F vs. 43 NF, p = 0.32). Progression free survival (PFS) and overall survival (OS) was similar between groups. Conclusion: Frailty was not associated with increased postoperative complication rate or worse survival in advanced endometrial cancer. Endometrial cancer surgery is largely performed minimally invasively which may be a factor that mitigates the adverse impact of frailty. Our small sample size limits interpretation: larger, multi-institutional studies are needed to determine whether surgical approach offsets the impact of frailty in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.